Riadh Gouider is an expert in Neurology at Hôpital Razi de La Manouba (Tunisia). As of June 2026, ScienceLeadR ranks Riadh Gouider in the top 1% of experts in Tunisia for Multiple Sclerosis, Proteostasis Deficiencies and Autoimmune Diseases. Riadh Gouider has authored 361 publications, the most recent in 2026, and is an investigator in 5 clinical trials. SLR score: 1,028 (community average: 125). How the SLR is computed.

LeadR Profile

Riadh Gouider Hôpital Razi de La Manouba Tunisia
1 028 ScienceLeadR Reputation 1028
Network Map

Neurology

Subspecialties: Public Health - Psychiatry - Immunology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1994 - 2026

Source: PubMed

Hôpital Razi de La Manouba

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 361

Citations

Citations: 3 094 1st author: 11 Last author: 198 Unique author: 4


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Determinants of self-management in Multiple Sclerosis: Insights from a Tunisian cross-sectional study.
PMID 42241784 — sclerosis, multiple sclerosis, self-management, cross-sectional studies, personality, self care, therapeutics
Mult Scler Relat Disord20260
Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis, including older patients and those with more advanced disease (ORATORIO-HAND): a multicentre, double-blind, randomised, placebo-controlled, phase 3b study.
PMID 42208561 — sclerosis, multiple sclerosis, safety, infections, primary progressive multiple sclerosis
Lancet Top journal20260
Predicting disease progression in multiple sclerosis with clinically accessible information and technology.
PMID 42002655 — sclerosis, multiple sclerosis, bias, disease progression, neurosurgery, therapeutics, learning, neurology
J Neurol20260
Migraine, headache disorders, and brain health: aligning advocacy with the UN Sustainable Development Goals.
PMID 41947032 — headache, sustainable development, brain, migraine disorders, headache disorders
J Headache Pain20260
Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study.
PMID 41935174 — sclerosis, multiple sclerosis, cohort studies, therapeutics
CNS Drugs20260

Clinical Studies 5

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

Phase 3 5

By status:

Completed 3
Active not recruiting 2

By type:

Interventional 5

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 1
multicentricup10 4

Main Topics

Cohort/Consortium Investigators 4

LeadR Networks

Main global connection map